1. Home
  2. PGEN vs MAGN Comparison

PGEN vs MAGN Comparison

Compare PGEN & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • MAGN
  • Stock Information
  • Founded
  • PGEN 1998
  • MAGN 1864
  • Country
  • PGEN United States
  • MAGN United States
  • Employees
  • PGEN N/A
  • MAGN N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • MAGN Paper
  • Sector
  • PGEN Health Care
  • MAGN Basic Materials
  • Exchange
  • PGEN Nasdaq
  • MAGN Nasdaq
  • Market Cap
  • PGEN 493.0M
  • MAGN 422.2M
  • IPO Year
  • PGEN N/A
  • MAGN N/A
  • Fundamental
  • Price
  • PGEN $4.18
  • MAGN $13.29
  • Analyst Decision
  • PGEN Buy
  • MAGN Hold
  • Analyst Count
  • PGEN 5
  • MAGN 1
  • Target Price
  • PGEN $7.50
  • MAGN $14.00
  • AVG Volume (30 Days)
  • PGEN 15.4M
  • MAGN 550.3K
  • Earning Date
  • PGEN 08-12-2025
  • MAGN 08-06-2025
  • Dividend Yield
  • PGEN N/A
  • MAGN N/A
  • EPS Growth
  • PGEN N/A
  • MAGN N/A
  • EPS
  • PGEN N/A
  • MAGN N/A
  • Revenue
  • PGEN $4,340,000.00
  • MAGN $2,919,000,000.00
  • Revenue This Year
  • PGEN $256.94
  • MAGN $47.87
  • Revenue Next Year
  • PGEN $759.81
  • MAGN $4.76
  • P/E Ratio
  • PGEN N/A
  • MAGN N/A
  • Revenue Growth
  • PGEN N/A
  • MAGN 34.21
  • 52 Week Low
  • PGEN $0.65
  • MAGN $10.39
  • 52 Week High
  • PGEN $4.21
  • MAGN $26.78
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 88.14
  • MAGN 54.31
  • Support Level
  • PGEN $2.94
  • MAGN $12.35
  • Resistance Level
  • PGEN $3.34
  • MAGN $13.26
  • Average True Range (ATR)
  • PGEN 0.32
  • MAGN 0.58
  • MACD
  • PGEN 0.22
  • MAGN 0.03
  • Stochastic Oscillator
  • PGEN 99.00
  • MAGN 83.09

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: